The FDA's regulation of mobile medical apps and other forms of health information technology is always a subject of speculation and intense scrutiny due to the arena's influx of new products and technological advancement. Stakeholders looked for clues to the FDA's intentions in its list of regulatory guidance documents that it intends to publish in 2015. Surprisingly, the issuance of its draft guidance on medical device interoperability was on the "B-list" of guidance that the agency hopes to publish in the upcoming year, as opposed to the "A-list" of guidance that will mostly likely be published. "It might be that the FDA expects other agencies will take the lead on interoperability, and perhaps they are planning to play a more supportive role," said lawyer Bradley Merrill Thompson of the law firm Epstein Becker Green. Story